Latest News
Keep up with what’s happening in the MPS community, industry and research.
**All Interesting Articles will get posted here with a link to download.
THIS JUST IN – NEW ARTICLE – Posted February 19, 2026
Compassion in Action: Simple, Creative Ways to Support a Loved One with a Chronic Condition
Written by: Jennifer McGregor, Public Health Library. (CLICK ON THE TITLE FOR FULL ARTICLE).
Living with a chronic condition reshapes daily life — not just for the individual but for everyone around them. Support, when done thoughtfully, can bring lightness, stability, and even humour into moments that might otherwise feel heavy. Let’s explore creative, compassionate, and practical ways to walk beside someone navigating long-term health challenges.
Quick Summary
Support means more than help — it’s about dignity, adaptability, and small acts that restore agency. Listen first. Simplify logistics. Encourage joy. Build systems that ease the daily load.
Being There Without Taking Over
Every chronic condition brings a rhythm of flare-ups and calm. The key is to match your pace to theirs — not to fix, but to synchronize.
- Listen without correction. Sometimes, empathy means silence.
- Offer choice, not pressure. “Would you like company today?” lands better than “You need to get out more.”
- Respect energy cycles. Some days will be “window days,” others “recovery days.” Both deserve recognition.
CLICK ON THE ARTICLE TITLE TO READ THE ENTIRE PIECE.
News Feed
News from the MPS Community, industry and research.
New Born Screening #NBS4MPS
The Canadian MPS Society has been strongly advocating to add MPS I-H (Hurler Syndrome) to all newborn screening panels throughout Canada. To date,...
Connect With Rare Disease Communities!
Ultragenyx has relaunched their patient support interactive website, UltraRareAdvocacy.com with a refreshed design and more ways to connect with...
NICE Recommends Vimizim For Treating MPS IVA Morquio
We are excited to hear that Elosulfase alfa - branded as Vimizin and made by BioMarin - has been recommended by NICE (National Institute for...
Recruiting for Clinical Trial: MPS-II (Hunter Syndrome) with Pabinafusp-Alfa
Mathias Schmidt, PhD, President and CEO of JCR Pharmaceuticals USA, discusses long-term efficacy and safety data of pabinafusp-alfa (Izcargo) in...
Current Treatment Options Explained for Hurler Syndrome
(MPS I) Raymond Wang, MD, Metabolic Specialist and Director of the Multidisciplinary Lysosomal Storage Disorder Program at Children’s Hospital of...
Advocacy Groups Unveil ‘Roadmap’ for Sanfilippo Research, Care
A coalition of patient advocacy organizations has published a Global Roadmap for Sanfilippo Syndrome therapies, in an effort to accelerate research...
Rapid Test Expected to Help in Developing Treatments for Sanfilippo
A new study shows a 30-minute, inexpensive, and easy-to-use test may help measure the activity of NDST1, one of the main enzymes involved in...
Abeona Ends Enrollment For MPS IIIA Clinical Trial
We are disappointed to hear that Abeona Therapeutics has decided to end enrollment for their clinical trial (Study ABT-003) for MPS IIIA children...
Resources for Courageous Parents
Courageous Parents Network is a non-profit organization and educational platform that orients, empowers and accompanies families and providers...
Research Highlights from the 2022 WORLD Symposium:
MPS I (Hurler syndrome) Orchard Therapeutics Announces Interim Data for OTL-203 Showing Positive Clinical Results in Multiple Disease Manifestations...









